← Back to Professional, Scientific, and Technical Services

Research and Development in Biotechnology

Industry Overview

Stock Screener

Select filters to narrow down the 175 companies below

175 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

CSL Ltd. - ADR

CSLLY

CSL Ltd. - ADR

CSLLY
Market Cap $118.26B
Dividends 2.3%
P/E Ratio -23.1
Revenue $7.44B +2.5%
Net Income -$2.99B -389.9%
Profit Margin -40.2%
View Stock

Genmab - ADR

GMAB

Genmab - ADR

GMAB
Market Cap $21.33B
Dividends 0.0%
P/E Ratio 26.5
Revenue $1.16B +24.9%
Net Income $303M -9.8%
Profit Margin +26.2%
View Stock

Exact Sciences Corp.

EXAS

Exact Sciences Corp.

EXAS
Market Cap $20.03B
Dividends 0.0%
P/E Ratio -188.6
Revenue $878M +23.1%
Net Income -$86M -90.1%
Profit Margin -9.8%
View Stock

Medpace Holdings Inc

MEDP

Medpace Holdings Inc

MEDP
Market Cap $16.73B
Dividends 0.0%
P/E Ratio 34.5
Revenue $707M +17.2%
Net Income $121M +34.5%
Profit Margin +17.2%
View Stock

Exelixis Inc

EXEL

Exelixis Inc

EXEL
Market Cap $14.68B
Dividends 0.0%
P/E Ratio 17.7
Revenue $629M +10.6%
Net Income $212M +14.7%
Profit Margin +33.7%
View Stock

Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

CRL
Market Cap $13.98B
Dividends 0.0%
P/E Ratio -60.0
Revenue $1B -2.7%
Net Income -$1.48M -102.8%
Profit Margin -0.1%
Employees 17K
View Stock

Icon Plc

ICLR

Icon Plc

ICLR
Market Cap $12.41B
Dividends 0.0%
P/E Ratio 37.8
Revenue $2.06B +2.3%
Net Income $72.6M -60.3%
Profit Margin +3.5%
View Stock

Twist Bioscience Corp

TWST

Twist Bioscience Corp

TWST
Market Cap $11.75B
Dividends 0.0%
P/E Ratio -85.0
Revenue $118M +23.2%
Net Income -$35.1M -271.9%
Profit Margin -29.6%
View Stock

Nuvalent Inc - Ordinary Shares - Class A

NUVL

Nuvalent Inc - Ordinary Shares - Class A

NUVL
Market Cap $9.13B
Dividends 0.0%
P/E Ratio -20.5
Revenue $0.00
Net Income -$109M +29.2%
Profit Margin
Employees 2.02K
View Stock

Crinetics Pharmaceuticals Inc

CRNX

Crinetics Pharmaceuticals Inc

CRNX
Market Cap $9B
Dividends 0.0%
P/E Ratio -16.8
Revenue $25.1M +2336.3%
Net Income -$121M +4.5%
Profit Margin -481.1%
View Stock

Immunovant Inc

IMVT

Immunovant Inc

IMVT
Market Cap $6.94B
Dividends 0.0%
P/E Ratio -11.9
Revenue $7.1M
Net Income -$153M +27.0%
Profit Margin -2159.6%
View Stock

Abivax - ADR

ABVX

Abivax - ADR

ABVX
Market Cap $6.82B
Dividends 0.0%
P/E Ratio -17.7
Revenue $0.00 -100.0%
Net Income -$117M +16.5%
Profit Margin
View Stock

Scholar Rock Holding Corp

SRRK

Scholar Rock Holding Corp

SRRK
Market Cap $5.61B
Dividends 0.0%
P/E Ratio -14.1
Revenue $0.00
Net Income -$110M -0.1%
Profit Margin
View Stock

Abcam - ADR (Sponsored)

ABCM

Abcam - ADR (Sponsored)

ABCM
Market Cap $5.52B
Dividends 0.0%
P/E Ratio 578.3
Revenue $102M +9.7%
Net Income $8.4M +189.7%
Profit Margin +8.3%
Employees 2.02K
View Stock

Erasca Inc

ERAS

Erasca Inc

ERAS
Market Cap $5.12B
Dividends 0.0%
P/E Ratio -15.5
Revenue $0.00
Net Income -$44.1M +30.1%
Profit Margin
Employees 2.02K
View Stock

Mirum Pharmaceuticals Inc

MIRM

Mirum Pharmaceuticals Inc

MIRM
Market Cap $5.06B
Dividends 0.0%
P/E Ratio -5.7
Revenue $176M +37.9%
Net Income -$67.2M +1047.0%
Profit Margin -38.1%
View Stock

Dianthus Therapeutics Inc

DNTH

Dianthus Therapeutics Inc

DNTH
Market Cap $4.93B
Dividends 0.0%
P/E Ratio -678.5
Revenue $761k +294.3%
Net Income -$50.2M +58.8%
Profit Margin -6598.6%
Employees 81
View Stock

Syneos Health Inc - Class A

SYNH

Syneos Health Inc - Class A

SYNH
Market Cap $4.46B
Dividends 0.0%
P/E Ratio 16.7
Revenue $1.37B +0.4%
Net Income $793k -99.0%
Profit Margin +0.1%
Employees 23K
View Stock

Tango Therapeutics Inc

TNGX

Tango Therapeutics Inc

TNGX
Market Cap $3.78B
Dividends 0.0%
P/E Ratio -27.3
Revenue $0.00 -100.0%
Net Income -$55.3M +42.4%
Profit Margin
Employees 4
View Stock

Ideaya Biosciences Inc

IDYA

Ideaya Biosciences Inc

IDYA
Market Cap $3.55B
Dividends 0.0%
P/E Ratio -19.5
Revenue $8.86M
Net Income -$112M +45.1%
Profit Margin -1269.6%
View Stock